Varex To Present At The Jefferies 2019 Healthcare Conference

SALT LAKE CITY, May 21, 2019 /PRNewswire/ — Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to make a presentation at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019 at 3:30 am Eastern Time. This event is being held at the Grand Hyatt New York in New York City.

The company’s Chief Financial Officer, Clarence Verhoef, will provide an overview of Varex’s business and prospects. Varex’s presentation will be webcast and accessible to the public via the company’s website at vareximaging.com. Replays will be available for 90 days after the presentation at the same website.

About Varex Imaging

Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 65+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose and protect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,000 people located at manufacturing and service center sites in North America, Europe, and Asia. For more information, visit vareximaging.com.

For Information Contact:
Howard Goldman
Director of Investor & Public Relations
Varex Imaging Corporation
801.978.5274 | howard.goldman@vareximaging.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/varex-to-present-at-the-jefferies-2019-healthcare-conference-300853792.html

SOURCE Varex Imaging Corporation

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

6 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

9 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

9 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

9 hours ago